Received Sep 11, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (MODERNA)) | MODERNA | UNK | — | IM |
a rash and swelling at the injection site/covid arm; a rash and swelling at the injection site/covid arm; This spontaneous case was reported by an other health care professional and describes the occurrence of VACCINATION SITE RASH (a rash and swelling at the injection site/covid arm) and VACCINATION SITE SWELLING (a rash and swelling at the injection site/covid arm) in a female patient of an unknown age who received SPIKEVAX NOS (SPIKEVAX NOS) for COVID-19 prophylaxis. No Medical History information was reported. On an unknown date, the patient received dose of SPIKEVAX NOS (SPIKEVAX NOS) (Intramuscular use) 1 dosage form. On an unknown date, received dose of SPIKEVAX NOS (SPIKEVAX NOS) (unknown route) dosage was changed to 1 dosage form and dose of SPIKEVAX NOS (SPIKEVAX NOS) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE RASH (a rash and swelling at the injection site/covid arm) and VACCINATION SITE SWELLING (a rash and swelling at the injection site/covid arm). At the time of the report, VACCINATION SITE RASH (a rash and swelling at the injection site/covid arm) and VACCINATION SITE SWELLING (a rash and swelling at the injection site/covid arm) had resolved. The action taken with SPIKEVAX NOS (SPIKEVAX NOS) (Intramuscular use) and SPIKEVAX NOS (SPIKEVAX NOS) (Unknown) was unknown. For SPIKEVAX NOS (SPIKEVAX NOS) (Unknown), the reporter did not provide any causality assessments. Concomitant medications were not reported. It was reported that patient experienced rash and swelling at the injection site after receiving the Moderna Covid vaccine on two out of three occasions. It was subsided in 4-7 days. It has been called COVID arm. The reporter was inquiring if this reaction was common and whether it was advisable for their patient to receive the new booster. It was unknown if the patient experienced any additional symptoms/events. Treatment information was not reported.